​

Bicara Therapeutics Ownership | Who Owns Bicara Therapeutics?

OverviewFinancialsChart

Bicara Therapeutics Ownership Summary

Bicara Therapeutics is owned by 85.84% institutional investors, 0.42% insiders, and 13.74% retail investors.

BCAX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockBicara Therapeutics85.84%0.42%13.74%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20248322.06%46,705,50728.51%851.92%62-8.82%7-
Sep 30, 202468-36,343,123-66-68---

Recent Insider Transactions

DateNameRoleActivityValue
Mar 14, 2025Meisner Lara Chief Legal OfficerSell$615.70K
Mar 14, 2025Meisner Lara Chief Legal OfficerSell$405.51K
Sep 16, 2024RA CAPITAL MANAGEMENT, L.P. Buy$30.25M
Sep 16, 2024RA CAPITAL MANAGEMENT, L.P. Buy$2.74M
Sep 17, 2024Flynn James E Possible Members of 10% GroupBuy$630.00K

Insider Transactions Trends

DateBuySell
2024 Q33-

BCAX Ownership FAQ

Who Owns Bicara Therapeutics?

Bicara Therapeutics shareholders are primarily institutional investors at 85.84%, followed by 0.42% insiders and 13.74% retail investors. The average institutional ownership in Bicara Therapeutics's industry, Biotech Stocks , is 68.48%, which Bicara Therapeutics exceeds.

Does Blackrock own Bicara Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Bicara Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools